ACLA Files Suit over FDA’s LDT Final Rule
The ACLA and HealthTrackRx sued the FDA, arguing that the agency’s new LDT rule improperly classifies lab testing services as medical devices.
Read MorePosted by Andy Lundin | Jun 3, 2024 | Compliance |
The ACLA and HealthTrackRx sued the FDA, arguing that the agency’s new LDT rule improperly classifies lab testing services as medical devices.
Read MorePosted by Andy Lundin | May 22, 2024 | Colorectal |
A new study found that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend.
Read MorePosted by Andy Lundin | May 21, 2024 | Compliance |
Senator Rand Paul announced a resolution to repeal the FDA’s LDT Final Rule, arguing it oversteps authority and threatens medical innovation.
Read MorePosted by Chris Wolski | May 15, 2024 | Lab Management |
Green initiatives can go a long ways to cut waste and positively impact the bottom line for clinical laboratories.
Read MorePosted by Andy Lundin | May 14, 2024 | Covid 19 |
The FDA warned against using Cue Health’s COVID tests due to modifications that reduced test reliability and increased risk of false results.
Read More